1. BioBridge Select:
Incorporating a New Product into
the Orthobiologics Line
Amber Laniewski
October 20, 2010

2. Components of the BioBridge Select Pitch
• Company Overview
• Company Mission
• Current Orthobiologics Line
• Suggestion to develop BioBridge Select
• Key Product Components
• Summary
• Conclusions
• Works Cited

3. Company Overview
Leader in the orthobiologics market
– Tissue Processing
– Distribution
Allograft and Xenograft product lines
Patented tissue sterilization processes
– BioCleanse
– Tutoplast
– Cancelle XP

4. RTI’s Mission
Commitment
to Advancing:
Science
Safety
Innovation

5. Current Orthobiologics Lines
• BTB Select
• Dermis
• Achilles Tendons
Sports
Medicine
• Fresh OC
• Fresh OC Talus
• Meniscus
Cartilage
• Cervical
• Thoraculumbar
Bone
Grafts

6. BioBridge Select
• Bone Graft Material that
will be used in spinal
repair surgery
• Will be sterilized by the
BioCleanse Sterilization
Process
• Will be directly
distributed nationally

7. BioBridge Select
Benefits to surgeons and patients
• Precision shaping
• Scientifically proven to be safe and effective
• Donor/recipient matching
• Convenient for surgeons

8. BioBridge Select
Commitment to Advancing Science, Safety and Innovation
Science
• Multiple
applications
• Clinically
approved
Safety
• Premier
processing
• Sterilization
without
irradiation
Innovation
• Market
demands
innovative
spinal bone
grafts

9. BioBridge Select
The future of the spinal grafting market
Market requires new
orthobiologics
product
Develop safe and
innovative product
Process and sterilize
new spinal grafting
material
Deliver positive ROI
and demonstrate
RTI’s dominance
BioBridge
Select

10. Works Cited
• All material used for this presentation was
acquired through the company intranet:
http://www.rtix.com/